Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model
Abstract: Background: The histamine H4 receptor (H4R) is preferentially expressed in immune cells and is a potential therapeutic target for inflammatory and autoimmune diseases. This study aimed at further exploring the role of H4R in the immunobiology of breast cancer. Methods: We used wild type (WT) and H4R deficient mice (KO) to evaluate whether H4R genotypes show a different distribution of T cell subsets in spleens, tumours and tumour draining lymph nodes (TDLN) in a syngeneic ErbB2-positive breast cancer model developed orthotopically with LM3 cells and its impact on tumour growth. Results: The presence of tumours had a differential impact on the distribution of T cells in TDLN from KO mice compared to WT ones. At day 21 post-inoculation (p.i.) of cells, despite no significant changes in the tumour weight, TDLN from KO mice showed a significantly increased proportion of CD8+ T cells compared to WT mice. At day 38 p.i. of cells a reduced tumour weight was evident in KO mice. This was accompanied by a decreased proportion of CD4+CD25+FoxP3+ regulatory T cells in TDLN of KO compared to WT mice. Tumour-bearing KO mice showed a better survival compared to WT mice. Conclusions: H4R-mediated mechanisms may modulate the immune tumour microenvironment, promoting an immunosuppressive milieu. Results suggest that H4R could be explored as an immunotherapeutic target with potential benefit in combination with immunotherapy. Further preclinical and clinical studies are necessary to confirm this hypothesis.
Main Authors: | , , , , , , , |
---|---|
Format: | Artículo biblioteca |
Language: | eng |
Published: |
Springer
2021
|
Subjects: | INMUNIDAD ANTITUMORAL, CANCER DE MAMA, HISTAMINA, CELULAS T, |
Online Access: | https://repositorio.uca.edu.ar/handle/123456789/14233 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:ucacris:123456789-14233 |
---|---|
record_format |
koha |
spelling |
oai:ucacris:123456789-142332023-03-01T15:29:48Z Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model Nicoud, Melisa Beatriz Táquez Delgado, Mónica Alejandra Sarasola, María de la Paz Vidal, María Agustina Speisky, Daniela Cremaschi, Graciela A. Sterle, Helena Andrea Medina, Vanina Araceli INMUNIDAD ANTITUMORAL CANCER DE MAMA HISTAMINA CELULAS T Abstract: Background: The histamine H4 receptor (H4R) is preferentially expressed in immune cells and is a potential therapeutic target for inflammatory and autoimmune diseases. This study aimed at further exploring the role of H4R in the immunobiology of breast cancer. Methods: We used wild type (WT) and H4R deficient mice (KO) to evaluate whether H4R genotypes show a different distribution of T cell subsets in spleens, tumours and tumour draining lymph nodes (TDLN) in a syngeneic ErbB2-positive breast cancer model developed orthotopically with LM3 cells and its impact on tumour growth. Results: The presence of tumours had a differential impact on the distribution of T cells in TDLN from KO mice compared to WT ones. At day 21 post-inoculation (p.i.) of cells, despite no significant changes in the tumour weight, TDLN from KO mice showed a significantly increased proportion of CD8+ T cells compared to WT mice. At day 38 p.i. of cells a reduced tumour weight was evident in KO mice. This was accompanied by a decreased proportion of CD4+CD25+FoxP3+ regulatory T cells in TDLN of KO compared to WT mice. Tumour-bearing KO mice showed a better survival compared to WT mice. Conclusions: H4R-mediated mechanisms may modulate the immune tumour microenvironment, promoting an immunosuppressive milieu. Results suggest that H4R could be explored as an immunotherapeutic target with potential benefit in combination with immunotherapy. Further preclinical and clinical studies are necessary to confirm this hypothesis. 2022-06-23T14:24:34Z 2022-06-23T14:24:34Z 2021 Artículo Nicoud, M.B., et al. Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model [en línea]. Cancer Immunology, Immunotherapy. 2021, 70(1) doi:10.1007/s00262-020-02672-y Disponible en: https://repositorio.uca.edu.ar/handle/123456789/14233 0340-7004 (impreso) 1432-0851 (online) https://repositorio.uca.edu.ar/handle/123456789/14233 10.1007/s00262-020-02672-y 32700092 eng info:eu-repo/semantics/closedAccess http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf Springer Cancer Immunology, Immunotherapy. 2021, 70(1) doi:10.1007/s00262-020-02672-y |
institution |
UCA |
collection |
DSpace |
country |
Argentina |
countrycode |
AR |
component |
Bibliográfico |
access |
En linea |
databasecode |
dig-uca |
tag |
biblioteca |
region |
America del Sur |
libraryname |
Sistema de bibliotecas de la UCA |
language |
eng |
topic |
INMUNIDAD ANTITUMORAL CANCER DE MAMA HISTAMINA CELULAS T INMUNIDAD ANTITUMORAL CANCER DE MAMA HISTAMINA CELULAS T |
spellingShingle |
INMUNIDAD ANTITUMORAL CANCER DE MAMA HISTAMINA CELULAS T INMUNIDAD ANTITUMORAL CANCER DE MAMA HISTAMINA CELULAS T Nicoud, Melisa Beatriz Táquez Delgado, Mónica Alejandra Sarasola, María de la Paz Vidal, María Agustina Speisky, Daniela Cremaschi, Graciela A. Sterle, Helena Andrea Medina, Vanina Araceli Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model |
description |
Abstract: Background: The histamine H4 receptor (H4R) is preferentially expressed in immune cells and is a potential therapeutic target for inflammatory and autoimmune diseases. This study aimed at further exploring the role of H4R in the immunobiology of breast cancer.
Methods: We used wild type (WT) and H4R deficient mice (KO) to evaluate whether H4R genotypes show a different distribution of T cell subsets in spleens, tumours and tumour draining lymph nodes (TDLN) in a syngeneic ErbB2-positive breast cancer model developed orthotopically with LM3 cells and its impact on tumour growth.
Results: The presence of tumours had a differential impact on the distribution of T cells in TDLN from KO mice compared to WT ones. At day 21 post-inoculation (p.i.) of cells, despite no significant changes in the tumour weight, TDLN from KO mice showed a significantly increased proportion of CD8+ T cells compared to WT mice. At day 38 p.i. of cells a reduced tumour weight was evident in KO mice. This was accompanied by a decreased proportion of CD4+CD25+FoxP3+ regulatory T cells in TDLN of KO compared to WT mice. Tumour-bearing KO mice showed a better survival compared to WT mice.
Conclusions: H4R-mediated mechanisms may modulate the immune tumour microenvironment, promoting an immunosuppressive milieu. Results suggest that H4R could be explored as an immunotherapeutic target with potential benefit in combination with immunotherapy. Further preclinical and clinical studies are necessary to confirm this hypothesis. |
format |
Artículo |
topic_facet |
INMUNIDAD ANTITUMORAL CANCER DE MAMA HISTAMINA CELULAS T |
author |
Nicoud, Melisa Beatriz Táquez Delgado, Mónica Alejandra Sarasola, María de la Paz Vidal, María Agustina Speisky, Daniela Cremaschi, Graciela A. Sterle, Helena Andrea Medina, Vanina Araceli |
author_facet |
Nicoud, Melisa Beatriz Táquez Delgado, Mónica Alejandra Sarasola, María de la Paz Vidal, María Agustina Speisky, Daniela Cremaschi, Graciela A. Sterle, Helena Andrea Medina, Vanina Araceli |
author_sort |
Nicoud, Melisa Beatriz |
title |
Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model |
title_short |
Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model |
title_full |
Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model |
title_fullStr |
Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model |
title_full_unstemmed |
Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model |
title_sort |
impact of histamine h4 receptor deficiency on the modulation of t cells in a murine breast cancer model |
publisher |
Springer |
publishDate |
2021 |
url |
https://repositorio.uca.edu.ar/handle/123456789/14233 |
work_keys_str_mv |
AT nicoudmelisabeatriz impactofhistamineh4receptordeficiencyonthemodulationoftcellsinamurinebreastcancermodel AT taquezdelgadomonicaalejandra impactofhistamineh4receptordeficiencyonthemodulationoftcellsinamurinebreastcancermodel AT sarasolamariadelapaz impactofhistamineh4receptordeficiencyonthemodulationoftcellsinamurinebreastcancermodel AT vidalmariaagustina impactofhistamineh4receptordeficiencyonthemodulationoftcellsinamurinebreastcancermodel AT speiskydaniela impactofhistamineh4receptordeficiencyonthemodulationoftcellsinamurinebreastcancermodel AT cremaschigracielaa impactofhistamineh4receptordeficiencyonthemodulationoftcellsinamurinebreastcancermodel AT sterlehelenaandrea impactofhistamineh4receptordeficiencyonthemodulationoftcellsinamurinebreastcancermodel AT medinavaninaaraceli impactofhistamineh4receptordeficiencyonthemodulationoftcellsinamurinebreastcancermodel |
_version_ |
1762928588448858112 |